Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (27)
Manxi Ge, Yan Zhu, Minjie Wei, Haozhe Piao & Miao He. (2023) Improving the efficacy of anti-EGFR drugs in GBM: Where we are going?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878:6, pages 188996.
Crossref
Crossref
Zuorun Xie, Maosong Chen, Jiangfang Lian, Hongcai Wang & Jingyun Ma. (2023) Glioblastoma-on-a-chip construction and therapeutic applications. Frontiers in Oncology 13.
Crossref
Crossref
Jan Korbecki, Mateusz Bosiacki, Izabela Gutowska, Dariusz Chlubek & Irena Baranowska-Bosiacka. (2023) Biosynthesis and Significance of Fatty Acids, Glycerophospholipids, and Triacylglycerol in the Processes of Glioblastoma Tumorigenesis. Cancers 15:7, pages 2183.
Crossref
Crossref
Kavitha Godugu, Bruce A Hay, Gennadi V Glinsky & Shaker A Mousa. (2023) Discovery of novel thyrointegrin αvβ3 antagonist fb-PMT (NP751) in the management of human glioblastoma multiforme. Neuro-Oncology Advances 5:1.
Crossref
Crossref
Rebecca C Abbott, Melinda Iliopoulos, Katherine A Watson, Valeria Arcucci, Margareta Go, Hannah E Hughes‐Parry, Pete Smith, Melissa J Call, Ryan S Cross & Misty R Jenkins. (2023)
Human
EGFRvIII
chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma
. Clinical & Translational Immunology 12:3.
Crossref
Crossref
Nusaibah Azman, Anani Aila Mat Zin, Sharifah Emilia Tuan Sharif & Ikmal Hisyam Bakrin. (2022) Detection of Isocitrate Dehydrogenase (IDH-1), Epidermal Growth Factor Receptor (EGFR), P53 and C-erbB2/HER2 Mutation in Glial Tumour. Malaysian Journal of Medicine and Health Sciences 18:s21, pages 111-119.
Crossref
Crossref
R. Dumke, C. Dumke, F. Eberle, Ch. Nimsky, U. Keber, R. Engenhart-Cabillic & S. Lautenschläger. (2022) Monocentric evaluation of Ki-67 labeling index in combination with a modified RPA score as a prognostic factor for survival in IDH-wildtype glioblastoma patients treated with radiochemotherapy. Strahlentherapie und Onkologie 198:10, pages 892-906.
Crossref
Crossref
Reem Altaf, Sarmad Sheraz Jadoon, Syed Aun Muhammad, Umair Ilyas & Yongtao Duan. (2022) Recent advances in immune checkpoint inhibitors for non-small lung cancer treatment. Frontiers in Oncology 12.
Crossref
Crossref
Sarmad Sheraz Jadoon, Umair Ilyas, Hajra Zafar, Ana Cláudia Paiva-Santos, Saifullah Khan, Saeed Ahmad Khan, Tanzeel Ahmed, Yasir Rasool, Reem Altaf, Faisal Raza & Muhammad Abbas. (2022) Genomic and Epigenomic Features of Glioblastoma Multiforme and its Biomarkers. Journal of Oncology 2022, pages 1-16.
Crossref
Crossref
Meihua Luo, Leo Kit Cheung Lee, Bo Peng, Chung Hang Jonathan Choi, Wing Yin Tong & Nicolas H. Voelcker. (2022) Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases. Advanced Science 9:26.
Crossref
Crossref
Michael E. Barish, Lihong Weng, Dina Awabdeh, Yubo Zhai, Renate Starr, Massimo D'Apuzzo, Russell C. Rockne, Haiqing Li, Behnam Badie, Stephen J. Forman & Christine E. Brown. (2022) Spatial organization of heterogeneous immunotherapy target antigen expression in high-grade glioma. Neoplasia 30, pages 100801.
Crossref
Crossref
Mattia Ghirardello, Radhe Shyam, Xia Liu, Teodoro Garcia-Millan, Imke Sittel, Javier Ramos-Soriano, Kathreena M. Kurian & M. Carmen Galan. (2022) Carbon dot-based fluorescent antibody nanoprobes as brain tumour glioblastoma diagnostics. Nanoscale Advances.
Crossref
Crossref
Shih-Yu Lee, I-Chuan Yen, Jang-Chun Lin, Min-Chieh Chung & Wei-Hsiu Liu. (2021)
4-Acetylantrocamol LT3 Inhibits Glioblastoma Cell Growth and Downregulates DNA Repair Enzyme O
6
-Methylguanine-DNA Methyltransferase
. The American Journal of Chinese Medicine 49:04, pages 983-999.
Crossref
Crossref
Rebecca C Abbott, Daniel J Verdon, Fiona M Gracey, Hannah E Hughes‐Parry, Melinda Iliopoulos, Katherine A Watson, Matthias Mulazzani, Kylie Luong, Colleen D’Arcy, Lucy C Sullivan, Ben R Kiefel, Ryan S Cross & Misty R Jenkins. (2021) Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma. Clinical & Translational Immunology 10:5.
Crossref
Crossref
Elmira Mohtashami, Negar Shafaei-Bajestani, Hamid Mollazadeh, Seyed Hadi Mousavi, Mohammad Jalili-Nik, Amirhossein Sahebkar & Amir R. Afshari. (2020) The Current State of Potential Therapeutic Modalities for Glioblastoma Multiforme: A Clinical Review. Current Drug Metabolism 21:8, pages 564-578.
Crossref
Crossref
Zhi‑Jian Cheng, Hong‑Qing Cai, Min‑Jie Zhang, Yi Zhong, Jie He, Qing Yuan, Jia‑Jie Hao, Ming‑Rong Wang & Jing‑Hai Wan. (2020) High S phase kinase‑associated protein 2 expression is a potential prognostic biomarker for glioma. Oncology Letters 20:3, pages 2788-2796.
Crossref
Crossref
Nina Struve, Zev A. Binder, Lucy F. Stead, Tim Brend, Stephen J. Bagley, Claire Faulkner, Leonie Ott, Justus Müller-Goebel, Anna-Sophie Weik, Konstantin Hoffer, Leonie Krug, Thorsten Rieckmann, Lara Bußmann, Marvin Henze, Jennifer J. D. Morrissette, Kathreena M. Kurian, Ulrich Schüller, Cordula Petersen, Kai Rothkamm, Donald M. O´ Rourke, Susan C. Short & Malte Kriegs. (2020) EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastoma. Oncogene 39:15, pages 3041-3055.
Crossref
Crossref
Xianping Liu, Chengjuan Du, Haichun Li, Ting Jiang, Zimiao Luo, Zhiqing Pang, Daoying Geng & Jun Zhang. (2019) Engineered superparamagnetic iron oxide nanoparticles (SPIONs) for dual-modality imaging of intracranial glioblastoma via EGFRvIII targeting. Beilstein Journal of Nanotechnology 10, pages 1860-1872.
Crossref
Crossref
Nadeem Abbas, Kausar, Wang, Zhao & Cui. (2019) Advances in Targeting the Epidermal Growth Factor Receptor Pathway by Synthetic Products and Its Regulation by Epigenetic Modulators As a Therapy for Glioblastoma. Cells 8:4, pages 350.
Crossref
Crossref
Takanori NOZAWA, Masayasu OKADA, Manabu NATSUMEDA, Takeyoshi EDA, Hideaki ABE, Yoshihiro TSUKAMOTO, Kouichirou OKAMOTO, Makoto OISHI, Hitoshi TAKAHASHI, Yukihiko FUJII & Akiyoshi KAKITA. (2019) EGFRvIII Is Expressed in Cellular Areas of Tumor in a Subset of Glioblastoma. Neurologia medico-chirurgica 59:3, pages 89-97.
Crossref
Crossref
Wojciech Szopa, Thomas A. Burley, Gabriela Kramer-Marek & Wojciech Kaspera. (2017) Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives. BioMed Research International 2017, pages 1-13.
Crossref
Crossref
Olle R. Lindberg, Andrew McKinney, Jane R. Engler, Gayane Koshkakaryan, Henry Gong, Aaron E. Robinson, Andrew J. Ewald, Emmanuelle Huillard, C. David James, Annette M. Molinaro, Joseph T. Shieh & Joanna J. Phillips. (2016) GBM heterogeneity as a function of variable epidermal growth factor receptor variant III activity. Oncotarget 7:48, pages 79101-79116.
Crossref
Crossref
Marina N. Nikiforova, Abigail I. Wald, Melissa A. Melan, Somak Roy, Shan Zhong, Ronald L. Hamilton, Frank S. Lieberman, Jan Drappatz, Nduka M. Amankulor, Ian F. Pollack, Yuri E. Nikiforov & Craig Horbinski. (2016) Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors. Neuro-Oncology 18:3, pages 379-387.
Crossref
Crossref
Tali Siegal. 2016. Advances and Technical Standards in Neurosurgery. Advances and Technical Standards in Neurosurgery
91
108
.
Tatiana Randriarimanana, Alicia Chateau, Béatrice Faivre, Sophie Pinel & Cédric Boura. (2015) Sensitivity of glioma initiating cells to a monoclonal anti-EGFR antibody therapy under hypoxia. Life Sciences 137, pages 74-80.
Crossref
Crossref
Ann-Marie Broome, Gopal Ramamurthy, Kari Lavik, Alexander Liggett, Ian Kinstlinger & James Basilion. (2015) Optical Imaging of Targeted β-Galactosidase in Brain Tumors to Detect EGFR Levels. Bioconjugate Chemistry 26:4, pages 660-668.
Crossref
Crossref
Tali Siegal. (2015) Clinical impact of molecular biomarkers in gliomas. Journal of Clinical Neuroscience 22:3, pages 437-444.
Crossref
Crossref